Get started
AMBU A/SAMBU A/SAMBU A/S

AMBU A/S

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

AMBU_B chart


Full chart

AMBU_B upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪33.67 B‬DKK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
75.10
Basic EPS (TTM)
1.70DKK
Net income (FY)
‪168.00 M‬DKK
Revenue (FY)
‪4.78 B‬DKK
Shares float
‪195.31 M‬
Beta (1Y)
0.37

Employees


Employees (FY)
‪4.62 K‬
Change (1Y)
+207 +4.69%
Revenue / Employee (1Y)
‪146.27 K‬DKK
Net income / Employee (1Y)
‪5.15 K‬DKK

About AMBU A/S


Sector
Health Technology
Industry
Medical Specialties
CEO
Britt Meelby Jensen
Website
ambu.com
Headquarters
Ballerup
Founded
1956
ISIN
DK0060946788
FIGI
BBG000BP3TK2
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

AMBU_B news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AMBU_B is 129.70 DKK — it has increased by 2.21% in the past 24 hours. Watch AMBU A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange AMBU A/S stocks are traded under the ticker AMBU_B.
AMBU_B stock has risen by 2.01% compared to the previous week, the month change is a −0.08% fall, over the last year AMBU A/S has showed a 84.44% increase.
We've gathered analysts' opinions on AMBU A/S future price: according to them, AMBU_B price has a max estimate of 145.00 DKK and a min estimate of 76.00 DKK. Watch AMBU_B chart and read a more detailed AMBU A/S stock forecast: see what analysts think of AMBU A/S and suggest that you do with its stocks.
AMBU_B reached its all-time high on Apr 27, 2021 with the price of 358.70 DKK, and its all-time low was 0.85 DKK and was reached on Mar 10, 2003. View more price dynamics on AMBU_B chart.
See other stocks reaching their highest and lowest prices.
AMBU_B stock is 3.33% volatile and has beta coefficient of 0.37. Track AMBU A/S stock price on the chart and check out the list of the most volatile stocks — is AMBU A/S there?
Today AMBU A/S has the market capitalization of ‪33.80 B‬, it has increased by 0.55% over the last week.
Yes, you can track AMBU A/S financials in yearly and quarterly reports right on TradingView.
AMBU A/S is going to release the next earnings report on Nov 5, 2024. Keep track of upcoming events with our Earnings Calendar.
AMBU_B earnings for the last quarter are 0.50 DKK per share, whereas the estimation was 0.51 DKK resulting in a −1.32% surprise. The estimated earnings for the next quarter are 0.51 DKK per share. See more details about AMBU A/S earnings.
AMBU A/S revenue for the last quarter amounts to ‪1.38 B‬ DKK, despite the estimated figure of ‪1.38 B‬ DKK. In the next quarter, revenue is expected to reach ‪1.42 B‬ DKK.
AMBU_B net income for the last quarter is ‪134.00 M‬ DKK, while the quarter before that showed ‪144.00 M‬ DKK of net income which accounts for −6.94% change. Track more AMBU A/S financial stats to get the full picture.
AMBU A/S dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 2, 2024, the company has ‪4.62 K‬ employees. See our rating of the largest employees — is AMBU A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMBU A/S EBITDA is ‪963.00 M‬ DKK, and current EBITDA margin is 13.24%. See more stats in AMBU A/S financial statements.
Like other stocks, AMBU_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMBU A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMBU A/S technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMBU A/S stock shows the buy signal. See more of AMBU A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.